A system is described for administration of radioactive and chemical aerosols to either 30 rats by nose-only exposure or two primates by exposure via tracheal tube. The total yield of exposure which was measured as the ratio between the radioactive amount in the nebulizer and the lung burden was about 2 · 10−4 for plutonium oxide particles. The reproducibility of the system of exposure, measured on 330 rats exposed during 11 sessions, and expressed as the standard deviation of logarithmic Gaussian distribution of the mean inhalation yield per session was 1.16. Also included are details of the apparatus in which such exposures may safely be performed.

Lung dissolution of industrial uranium tetrafluoride (UF4) was tested in rats and baboons by intratracheal instillation and inhalation, to check the W classification given to UF4 by the International Commission on Radiological Protection. Rats and baboons were given 10 and 160 micrograms of UF4 per animal respectively. Lung clearance, urinary excretion and tissue distribution of uranium were measured in rats, and urinary excretion was measured in baboons. After intratracheal instillation, daily urinary excretion was fast in both species; 4.8 +/- 0.7 X 10(-2) of the initial lung burden (ILB) in rats and 2.9 +/- 0.3 X 10(-2) in baboons. After inhalation of dry UF4 powder, daily urinary excretion was 5.6 +/- 2.2 X 10(-2) of the ILB in rats and the lung clearance half-life was 7.3 d. The amounts of uranium excreted by rats and baboons were compared to the amounts dissolved in vitro by alveolar macrophages from both species, and also to the amount dissolved chemically by a serum simulant. Both rat and baboon macrophages were clearly shown to be involved in the mechanism of uranium dissolution, since on the first day of macrophage culture, they dissolved 20 and 40% respectively of the amounts of UF4 added to the macrophage cultures, again illustrating the fast dissolution of UF4.(ABSTRACT TRUNCATED AT 250 WORDS)

The effect of size of plutonium particles on survival and cancer incidence in lung and extrapulmonary sites was studied in two groups of rats. One group inhaled PuO2 particles, prepared at 1000°C (CMD = 0.6μm), and the second group received particles resulting from a fire of Pu-Mg alloy (CMD = 0.33 μm for respirable fraction consisting of aggregates of fine particles, CMD = 0.04 μm). We observed that survival decreased with increasing plutonium exposure but was comparable in the two groups.

The solubility of two industrial forms of beryllium, i.e. particles of metal powder and particles of hot-pressed beryllium, was investigated using in vivo and in vitro models. In the in vivo model, baboons and rats were used and were injected via the trachea with amounts of beryllium equivalent to 100, 500 and 1000 fold the maximum permissible concentration (MPC) recommended by the US Occupational Safety and Health Administration. In vivo experiments showed that in both species the daily beryllium solubility rates were about 5 x 10-6 for metal particles and that in rats the daily beryllium solubility rate was about 5 x 10-5 for the hot-pressed particles. During the 10 months of the experiment with baboons, urinary excretion of beryllium was proportional to the amount administered. With regard to results for the in vitro models, the outcome of the acellular dissolution test using a serum simulant was not consistent with the in vivo results, though a cellular model using cultured macrophages showed the same trends in the dissolution rates for the two forms of beryllium as those observed in vivo. This result suggests that a cellular rather than an acellular dissolution model would be better at predicting solubility of beryllium compounds in the lungs.